???global.info.a_carregar???
Dani¿l Filipe Miranda Mendanha, born on May 10th in Braga, Portugal, is a researcher in biotechnology. He earned a Bachelor's in Applied Biology in 2014 and a Master's in Health Sciences in 2016 from the University of Minho, with a focus on glioblastoma research. He increased his expertise by completing a laboratory animal science course, which granted him a FELASA category C certification. In September 2018, he was awarded a PhD scholarship from the FCT to enroll in the Tissue Engineering, Regenerative Medicine, and Stem Cells Doctoral Program. In 2024, he obtained a PhD degree from the 3B’s Research Group at the University of Minho, focusing on the development of new drug delivery systems for glioblastoma therapy. Currently, Daniel is working at CITEVE, Portugal, in the Chemistry and Biotechnology Department, researching new bioproducts for technical textile applications. To this date, his track record of innovation and research includes 4 first-author peer-reviewed original papers. During his short career, he has also attended several international meetings, giving one oral presentation, and presenting seven poster communications.
Ler resumo completo ↓
Identificação

Identificação pessoal

Nome completo
Daniel Filipe Miranda Mendanha

Nomes de citação

  • Mendanha, D

Identificadores de autor

Ciência ID
9F18-BA53-8C9F
ORCID iD
0000-0002-9122-2658

Telefones

Telemóvel
  • 913184484 (Pessoal)

Moradas

  • R. Fernando Mesquita 2785, 4760-034, Vila Nova de Famalicão, Braga, Portugal (Profissional)

Domínios de atuação

  • Ciências Médicas e da Saúde - Biotecnologia Médica - Tecnologias que envolvem a Manipulação de Células,Tecidos,Órgãos ou todo o Organismo

Idiomas

Idioma Conversação Leitura Escrita Compreensão Peer-review
Português (Idioma materno)
Inglês Utilizador proficiente (C1) Utilizador proficiente (C1) Utilizador proficiente (C1) Utilizador proficiente (C1) Utilizador proficiente (C1)
Formação
Grau Classificação
2018/01/09 - 2024/01/25
Concluído
 Engenharia de Tecidos, Medicina Regenerativa e Células Estaminais (Doutoramento)
Universidade do Minho, Portugal
"Development of controlled drug delivery systems for the treatment of glioblastoma" (TESE/DISSERTAÇÃO)
2014/09/01 - 2016/06/17
Concluído
 Ciências da Saúde (Mestrado)
Especialização em Oncologia
Universidade do Minho Escola de Medicina, Portugal
"Understanding the relevance of astrocytic vesicular release in glioblastoma " (TESE/DISSERTAÇÃO)
 17
2011/09/01 - 2014/07/25
Concluído
 Biologia Aplicada (Licenciatura)
Universidade do Minho, Portugal
"The effect of alcohol in the induction of DNA damage in cell culture" (TESE/DISSERTAÇÃO)
 16
Percurso profissional

Ciência

Categoria Profissional
Instituição de acolhimento 		Empregador
2023/10/01 - Atual Investigador (Investigação) Centro Tecnológico das Indústrias Têxtil e do Vestuário de Portugal, Portugal
Produções

Publicações

Artigo em revista
  1. D. Mendanha; S. Gimondi; B.M. Costa; H. Ferreira; N.M. Neves. "Microfluidic-derived docosahexaenoic acid liposomes for glioblastoma therapy". Nanomedicine: Nanotechnology, Biology and Medicine (2023): http://dx.doi.org/10.1016/j.nano.2023.102704.
    10.1016/j.nano.2023.102704
  2. D. Mendanha; J. Vieira de Castro; M.R. Casanova; S. Gimondi; H. Ferreira; N.M. Neves. "Macrophage cell membrane infused biomimetic liposomes for glioblastoma targeted therapy". Nanomedicine: Nanotechnology, Biology and Medicine (2023): http://dx.doi.org/10.1016/j.nano.2023.102663.
    10.1016/j.nano.2023.102663
  3. "Biomimetic and cell-based nanocarriers – New strategies for brain tumor targeting". Journal of Controlled Release (2021): http://dx.doi.org/10.1016/j.jconrel.2021.07.047.
    10.1016/j.jconrel.2021.07.047
  4. Daniel Mendanha; Joana Vieira de Castro; Joana Moreira; Bruno M. Costa; Honorina Cidade; Madalena Pinto; Helena Ferreira; Nuno M. Neves. "A New Chalcone Derivative with Promising Antiproliferative and Anti-Invasion Activities in Glioblastoma Cells". Molecules 26 11 (2021): 3383-3383. https://doi.org/10.3390/molecules26113383.
    10.3390/molecules26113383
Poster em conferência
  1. Mendanha, Daniel; Vieira de Castro, J; Ferreira,H; Neves,NM. "Development of personalized drug delivey systems by exploiting secretome of glioblastoma cells". Trabalho apresentado em TERM STEM 2019, 2019.
  2. Mendanha, Daniel; Vieira de Castro,J; Ferreira,H; Neves,NM. "Development of targeted drug delivery systems by exploiting autocrine regulation of glioblastoma cells". Trabalho apresentado em 1st Discoveries Forum on Regenerative and Precision Medicine, 2019.
  3. Mendanha, Daniel. "Exploitation of the autocrine regulation of glioblastoma cells to develop nanoparticle based targeted therapies". Trabalho apresentado em FoReCaST Second Workshop;"Nanotechnology in cancer detection and treatment:from the lab to the clinic"., 2019.
  4. Mendanha, Daniel; Pojo,M; Oliveira, AI; Guerra-Gomes, S; Costa, BM; Oliveira, JF. "Understanding the revelance of astrocytic vesicular release in Glioblastoma". Trabalho apresentado em IX NeRD Retreat, 2015.
  5. Guerra-Gome, S; Mendanha, Daniel; Sardinha, VM; Tavares, G; Correia, JS; Sousa, N;; Oliveira, JF. "Age related cognitive impact in a trasngenic model of astrocytic dysfunction". Trabalho apresentado em Glia meeting - XII European Meeting on Glial Cell Function in Health and Disease, 2015.
  6. Martins, M; Guerra-Gomes, S; Sardinha, VM; Mendanha, Daniel; Correia, JS; Tavares, G; Oliveira, JF. "Impact of astrocytic exocytosis in aged dnSNARE mice". Trabalho apresentado em XIV Meeting of the portuguese Society of Neurosciences, 2015.
Tese / Dissertação
  1. Mendanha, Daniel Filipe Miranda. "Development of controlled drug delivery systems for the treatment of glioblastoma". Doutoramento, 2024. https://hdl.handle.net/1822/88376.
  2. Mendanha, Daniel Filipe Miranda. "Understanding the relevance of astrocytic vesicular release in glioblastoma". Mestrado, 2016. https://hdl.handle.net/1822/46901.